The FDA approved Lupin's levetiracetam oral solution, a generic version of UCB's epilepsy treatment Keppra. Last month, Lupin received marketing approval for the generic's extended-release formulation.
FDA permits Lupin to sell generic of epilepsy drug Keppra
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||